![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Real-Life Efficacy and Tolerability of Lacosamide in Pediatric Patients Aged 4 Years or Older with Drug-Resistant Epilepsy |
Shin Yun Byun, Juhyun Kong, Soo Young Lyu, Sang Ook Nam, Young Mi Kim, Gyu Min Yeon, Yun-Jin Lee |
Ann Child Neurol. 2023;31(3):206-214. Published online June 20, 2023 DOI: https://doi.org/10.26815/acn.2023.00073 |
Real-Life Efficacy and Tolerability of Lacosamide in Pediatric Patients Aged 4 Years or Older with Drug-Resistant Epilepsy Long-term efficacy and safety of adjunctive perampanel in pediatric patients aged 4 – 19 years with drug-resistant epilepsy: a real-world study Tolerability of clobazam as add-on therapy in patients aged 50 years and older with drug-resistant epilepsy Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmacoresistant focal epilepsy The Efficacy of Lacosamide in Children with Drug-Resistant Epilepsy: Three Cases in Pediatric Patients Real-Life Effectiveness and Tolerability of Perampanel in Pediatric Patients Aged 4 Years or Older with Epilepsy: A Korean National Multicenter Study Twelve-Month Efficacy of Lacosamide Monotherapy at Maximal Dose and Tolerability for Epilepsy Treatment in Pediatric Patients: Real-World Clinical Experience Drug-resistant epilepsy in MELAS: safety and potential efficacy of lacosamide Efficacy, Tolerability, and Safety of Treatment With Perampanel in Pediatric Patients With Epilepsy Aged ≥4 Years: A Real-Life Observational Study Effectiveness and tolerability of lacosamide in children with drug resistant epilepsy |